ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

AACR Supports Bypass Budget; Public Consortium Sequences Mouse Genome

May 10, 2002

A Conversation with MSKCC’s José Baselga: We Need to Increase Our Reach

September 27, 2013

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984

NCI Offers Bibliography On Risk Communication.

March 23, 2001